INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Invivo Therapeutics Holdings Corp. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Debt-to-equity for the quarter ending September 30, 2023 was 15.4 %, a 33.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 15.4 -7.9 -33.8% Sep 30, 2023
Q2 2023 20.2 +1.53 +8.21% Jun 30, 2023
Q1 2023 22.6 +7.41 +48.9% Mar 31, 2023
Q4 2022 23.3 +10.8 +87% Dec 31, 2022
Q3 2022 23.3 +12.1 +107% Sep 30, 2022
Q2 2022 18.7 +5.34 +40.1% Jun 30, 2022
Q1 2022 15.2 -1.3 -7.89% Mar 31, 2022
Q4 2021 12.5 -11.2 -47.3% Dec 31, 2021
Q3 2021 11.3 -25.2 -69.2% Sep 30, 2021
Q2 2021 13.3 -24.9 -65.1% Jun 30, 2021
Q1 2021 16.5 -22.5 -57.7% Mar 31, 2021
Q4 2020 23.7 -12.7 -34.9% Dec 31, 2020
Q3 2020 36.5 +11.2 +44.5% Sep 30, 2020
Q2 2020 38.2 +18 +89.2% Jun 30, 2020
Q1 2020 39 -35.6 -47.7% Mar 31, 2020
Q4 2019 36.3 -51.5 -58.6% Dec 31, 2019
Q3 2019 25.3 -82.3 -76.5% Sep 30, 2019
Q2 2019 20.2 -107 -84.1% Jun 30, 2019
Q1 2019 74.5 +40 +116% Mar 31, 2019
Q4 2018 87.8 +61.2 +231% Dec 31, 2018
Q3 2018 108 +84.6 +369% Sep 30, 2018
Q2 2018 127 +106 +502% Jun 30, 2018
Q1 2018 34.6 +15.6 +82.6% Mar 31, 2018
Q4 2017 26.6 +9.11 +52.2% Dec 31, 2017
Q3 2017 23 +4.64 +25.3% Sep 30, 2017
Q2 2017 21.1 -0.05 -0.24% Jun 30, 2017
Q1 2017 18.9 -14 -42.6% Mar 31, 2017
Q4 2016 17.4 -50.5 -74.3% Dec 31, 2016
Q3 2016 18.3 -77.2 -80.8% Sep 30, 2016
Q2 2016 21.1 -81.4 -79.4% Jun 30, 2016
Q1 2016 33 -67.5 -67.2% Mar 31, 2016
Q4 2015 67.9 -5.31 -7.25% Dec 31, 2015
Q3 2015 95.5 +45.8 +92.4% Sep 30, 2015
Q2 2015 103 +61.6 +151% Jun 30, 2015
Q1 2015 100 +75.1 +297% Mar 31, 2015
Q4 2014 73.2 -30.5 -29.4% Dec 31, 2014
Q3 2014 49.6 -183 -78.6% Sep 30, 2014
Q2 2014 40.9 -523 -92.7% Jun 30, 2014
Q1 2014 25.3 +556 Mar 31, 2014
Q4 2013 104 +963 Dec 31, 2013
Q3 2013 232 +501 Sep 30, 2013
Q2 2013 564 +779 Jun 30, 2013
Q1 2013 -531 -345 -186% Mar 31, 2013
Q4 2012 -860 Dec 31, 2012
Q3 2012 -269 Sep 30, 2012
Q2 2012 -215 Jun 30, 2012
Q1 2012 -185 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.